compounds to treat the obesity. Furthermore, in March, 2019, Merck and Co and NGM
Biopharmaceuticals developed new range of obesity management drugs.
Key players operating in the global anti-obesity drugs market include Arena Pharmaceuticals
Inc., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Orexigen Therapeutics Inc., Norgine B.V.,
Pfizer Inc., Merck Co& Inc., Takeda Pharmaceuticals Co. Ltd., Zydus Cadila, Novo Nordisk,
Zafgen, GlaxoSmithKline PLC, and Hoffmann-La Roche AG
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/anti-obesity-drugs-market-2824
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702